Dissociation between vascular oxidative stress and cardiovascular function in Wistar Kyoto and spontaneously hypertensive rats

Vascular Pharmacology

Volumn 45, Issue 2, 2006, Pages 112-121

  Sicard, Pierre ^a   Oudot, Alexandra ^a   Guilland, Jean Claude ^a   Moreau, Daniel ^a   Vergely, Catherine ^a   Rochette, Luc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Free radicals; Hypertension; Ischemia reperfusion; Matrix metalloproteinase; NAD(P)H oxidase

Indexed keywords

ASCORBIC ACID; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DISSOCIATION; DRUG MEGADOSE; ELECTRON SPIN RESONANCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEMODYNAMIC MONITORING; INFLAMMATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VITAMIN SUPPLEMENTATION;

EID: 33748681987     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.04.001     Document Type: Article

References (49)

1. Bank A.J., Rector T.S., Tschumperlin L.K., Kraemer M.D., Letourneau J.G., and Kubo S.H. Endothelium-dependent vasodilation of peripheral conduit arteries in patients with heart failure. J. Card. Fail. 1 (1994) 35-43
2. Bauersachs J., Bouloumie A., Mulsch A., Wiemer G., Fleming I., and Busse R. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc. Res. 37 (1998) 772-779
3. Belichard P., Pruneau D., and Rochette L. Influence of spontaneous hypertension and cardiac hypertrophy on the severity of ischemic arrhythmias in the rat. Basic Res. Cardiol. 83 (1988) 560-566
4. Buettner G.R., and Jurkiewicz B.A. Ascorbate free radical as a marker of oxidative stress: an EPR study. Free Radic. Biol. Med. 14 (1993) 49-55
5. Busseuil D., Zeller M., Cottin Y., Maingon P., Barillot I., Allouch P., Ponnelle T., Bril A., Briot F., Wolf J.E., and Rochette L. Late neointimal tissue growth behind the stent after intravascular gamma-radiation. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 259-266
6. Cao G., Alessio H., and Culter R. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic. Biol. Med. 14 (1993) 303-311
7. Capers Q.t., Alexander R.W., Lou P., De Leon H., Wilcox J.N., Ishizaka N., Howard A.B., and Taylor W.R. Monocyte chemoattractant protein-1 expression in aortic tissues of hypertensive rats. Hypertension 30 (1997) 1397-1402
8. Carr A.C., Zhu B.Z., and Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ. Res. 87 (2000) 349-354
9. Challem J., and Taylor E. Retroviruses, ascorbate, and mutations, in the evolution of Homo sapiens. Free Radic. Biol. Med. 25 (1998) 130-132
10. Chen X., Touyz R.M., Park J.B., and Schiffrin E.L. Antioxidant effects of vitamin C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38 part 2 (2001) 606-611
11. Delbosc S., Morena M., Djouad F., Ledoucen C., Descomps B., and Cristol J.P. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J. Cardiovasc. Pharmacol. 40 (2002) 611-617
12. de Saram K., McNeill K.L., Khokher S., Ritter J.M., and Chowienczyk P.J. Divergent effects of vitamin C on relaxations of rabbit aortic rings to acetylcholine and NO-donors. Br. J. Pharmacol. 135 (2002) 1044-1050
13. d'Uscio L.V., Milstien S., Richardson D., Smith L., and Katusic Z.S. Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ. Res. 92 (2003) 88-95
14. Elmarakby A.A., Loomis E.D., Pollock J.S., and Pollock D.M. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45 (2005) 283-287
15. Ettarh R.R., Odigie I.P., and Adigun S.A. Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can. J. Physiol. Pharm. 80 (2002) 1199-1202
16. Fujita I., Akagi Y., Hirano J., Nakanishi T., Itoh N., Muto N., and Tanaka K. Distinct mechanisms of transport of ascorbic acid and dehydroascorbic acid in intestinal epithelial cells (IEC-6). Res. Commun. Mol. Pathol. Pharmacol. 107 (2000) 219-231
17. Galis Z.S., Asanuma K., Godin D., and Meng X. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?. Circulation 97 (1998) 2445-2453
18. Gao F., Yao C.-L., Gao E., Mo Q.-Z., Yan W.-L., McLaughlin R., Lopez B.L., Christopher T.A., and Ma X.L. Enhancement of glutathione cardioprotection by ascorbic acid in myocardial reperfusion injury. J. Pharmacol. Exp. Ther. 301 (2002) 543-550
19. Grossmann M., Dobrev D., Himmel H.M., Ravens U., and Kirch W. Ascorbic acid-induced modulation of venous tone in humans. Hypertension 37 (2001) 949-954
20. Grote K., Flach I., Luchtefeld M., Akin E., Holland S.M., Drexler H., and Schieffer B. Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD(P)H oxidase-derived reactive oxygen species. Circ. Res. 92 (2003) e80-e86
21. Han K.H., Ryu J., Hong K.H., Ko J., Pak Y.K., Kim J.B., Park S.W., and Kim J.J. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation 111 (2005) 1439-1447
22. Hughes J.M., and Bund S.J. Arterial myogenic properties of the spontaneously hypertensive rat. Exp. Physiol. 87 (2002) 527-534
23. Inoue N., Takeshita S., Gao D., Ishida T., Kawashima S., Akita H., Tawa R., Sakurai H., and Yokoyama M. Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 155 (2001) 45-52
24. Ishibashi M., Hiasa K., Zhao Q., Inoue S., Ohtani K., Kitamoto S., Tsuchihashi M., Sugaya T., Charo I.F., Kura S., Tsuzuki T., Ishibashi T., Takeshita A., and Egashira K. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ. Res. 94 (2004) 1203-1210
25. Jackson T.S., Xu A., Vita J.A., and Keaney J.F. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 83 (1998) 916-922
26. Kc S., Carcamo J.M., and Golde D.W. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury. FASEB J. 19 (2005) 1657-1667
27. Kozlov A.V., Szalay L., Umar F., Fink B., Kropik K., Nohl H., Redl H., and Bahrami S. Epr analysis reveals three tissues responding to endotoxin by increased formation of reactive oxygen and nitrogen species. Free Radic. Biol. Med. 34 (2003) 1555-1562
28. Lehoux S., Lemarie C.A., Esposito B., Lijnen H.R., and Tedgui A. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 109 (2004) 1041-1047
29. Lehr H.A., Frei B., and Arfors K.E. Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7688-7692
30. Levine G.N., Frei B., Koulouris S.N., Gerhard M.D., Keaney J.F., and Vita J.A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93 (1996) 1107-1113
31. Liang W.J., Johnson D., and Jarvis S.M. Vitamin C transport systems of mammalian cells. Mol. Membr. Biol. 18 (2001) 87-95
32. McVeigh G.E., Hamilton P., Wilson M., Hanratty C.G., Leahey W.J., Devine A.B., Morgan D.G., Dixon L.J., and McGrath L.T. Platelet nitric oxide and superoxide release during the development of nitrate tolerance: effect of supplemental ascorbate. Circulation 106 (2002) 208-213
33. Orbe J., Rodriguez J.A., Arias R., Belzunce M., Nespereira B., Perez-Ilzarbe M., Roncal C., and Paramo J.A. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 167 (2003) 45-53
34. Oudot A., Vergely C., Ecarnot-Laubriet A., and Rochette L. Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion. Eur. J. Pharmacol. (2003) 462
35. Payne J.A., Reckelhoff J.F., and Khalil R.A. Role of oxidative stress in age-related reduction of NO-cGMP-mediated vascular relaxation in SHR. Am. J. Physiol. 285 (2003) R542-R551
36. Pu Q., and Schiffrin E.L. Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 14 (2001) 1067-1072
37. Rajagopalan S., Meng X.P., Ramasamy S., Harrison D.G., and Galis Z.S. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98 (1996) 2572-2579
38. Romero J.C., and Reckelhoff J.F. State-of-the-Art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 34 (1999) 943-949
39. Rose R.C., and Bode A.M. Biology of free radical scavengers: an evaluation of ascorbate. FASEB J. 7 (1993) 1135-1142
40. Rumsey S., and Levine M. Absorption, transport, and disposition of ascorbic acid in humans. J. Nutr. Biochem 9 (1998) 116-130
41. Tessier F., Birlouez-Aragon I., Tjani C., and Guilland J.-C. Validation of a micromethod for determining oxidized and reduced vitamin C in plasma by HPLC-fluorescence. Int. J. Vitam. Nutr. Res. 66 (1996) 166-170
42. Timimi F.K., Ting H.H., Haley E.A., Roddy M.-A., Ganz P., and Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 31 (1998) 552-557
43. Touyz R.M. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II-editorial review. Curr. Opin. Nephrol. Hypertens. 14 (2005) 125-131
44. Ulker S., McMaster D., McKeown P.P., and Bayraktutan U. Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc. Res. 59 (2003) 488-500
45. van Gorp A.W., Schenau D.S., Hoeks A.P., Boudier H.A., de Mey J.G., and Reneman R.S. In spontaneously hypertensive rats alterations in aortic wall properties precede development of hypertension. Am. J. Physiol, Heart Circ. Physiol. 278 (2000) H1241-H1247
46. Vergely C., Maupoil V., Benderitter M., and Rochette L. Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on post-ischemic recovery during reperfusion. Free Radic. Biol. Med. 24 (1998) 470-479
47. Vergely C., Goirand F., Ecarnot-Laubriet A., Renard C., Moreau D., Guilland J.C., Dumas M., and Rochette L. Vitamin C deficiency exerts paradoxical cardiovascular effects in Osteogenic Disorder Shionogi (ODS) rats. J. Nutr. 134 (2004) 729-735
48. Wayner D., Burton G., Ingold K., Barclay L., and Locke S. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Biochim. Biophys. Acta 924 (1987) 408-419
49. Yang D., Feletou M., Boulanger C., Wu H., Levens N., Zhang J., and Vanhoutte P. Oxygen-derived free radicals mediate endothelium-dependent contractions to acetylcholine in aortas from spontaneously hypertensive rats. Br. J. Pharmacol. 136 (2002) 104-110